Jiachen Yang
Osaka University
H-index: 39
Asia-Japan
Top articles of Jiachen Yang
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer | Journal of Clinical Oncology | David R Spigel Afshin Dowlati Yuanbin Chen Alejandro Navarro James Chih-Hsin Yang | 2024/4 |
38P Real-world treatment patterns and effectiveness of subsequent treatments following first-line (1L) brigatinib for patients with anaplastic lymphoma kinase positive (ALK+ … | ESMO Open | A Delmonte MJ Ahn S Ghosh MJ Hochmair TY Yang | 2024/3/1 |
1348P Management of paresthesia in patients treated with lazertinib: Integrated analysis of LASER201 and LASER301 studies | Annals of Oncology | YG Lee JS Ahn MJ Ahn JH Kang RA Soo | 2023/10/1 |
OA21. 06 ctDNA Dynamics, Prognostic Markers and Resistance Mechanisms in Tepotinib-Treated METex14 Skipping NSCLC in the VISION Trial | Journal of Thoracic Oncology | X Le MC Garassino M-J Ahn E Felip AB Cortot | 2023/11/1 |
30 Long-term efficacy, safety, and predictors of response to amivantamab among patients with post-platinum EGFR Ex20ins-mutated advanced NSCLC | Journal of Thoracic Oncology | P Garrido Lopez N Girard BC Cho J Sabari A Spira | 2023/4/1 |
PCR105 Patient Risk-Benefit Preferences for Transcatheter Versus Surgical Mitral Valve Repair | Value in Health | A Hung JC Yang M Wallace B Zwischenberger S Vemulapalli | 2023/6/1 |
P2. 11-02 Tepotinib in Asian Patients with MET exon 14 Skipping Non-small Cell Lung Cancer (NSCLC) in Long-term Follow-up From VISION | Journal of Thoracic Oncology | M-J Ahn T Kato JC-H Yang H Sakai M Morise | 2023/11/1 |
PCR106 Comparing Maximum-Acceptable Risk Estimates from 2 Preference-Elicitation Methods: A Discrete-Choice Experiment and a Threshold-Technique Exercise | Value in Health | J Sutphin M Wallace JC Yang MA Corriere EA Secemsky | 2023/6/1 |
LBA56 Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC) | Annals of Oncology | JD Spicer S Gao M Liberman T Kato M Tsuboi | 2023/10/1 |
PL03. 13 osimertinib with/without platinum-based chemotherapy as first-line treatment in patients with EGFRm advanced NSCLC (FLAURA2) | Journal of Thoracic Oncology | P Janne D Planchard Y Cheng JC-H Yang N Yanagitani | 2023/11/1 |
PCR40 Waiting for a Good Kidney: Do Patients Think It’s Worth It? | Value in Health | CH Wu JM Gonzalez JC Yang S Mehrotra SD Reed | 2023/6/1 |
Effect of Dose to the Heart and Cardiac Substructures on Cardiac Toxicity after Breast Cancer Radiation | International Journal of Radiation Oncology, Biology, Physics | JS Hogan B Kalaghchi T Agabalogun J Hilliard J Kavanaugh | 2023/10/1 |
552P TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in Asian patients (pts) with previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs) | Annals of Oncology | MJ Ahn BC Cho Y Goto K Yoh WC Su | 2023/11/1 |
Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey | ESMO open | Helena Linardou AA Adjei J Bajpai Susana Banerjee Anna Sophie Berghoff | 2023/4/1 |
Impact of Stomach Deformability on PTV Coverage in Patients with Gastric MALTs Treated with Deep Inspiration Breath Hold (DIBH) and Daily CT-based Image-guided Radiation … | International Journal of Radiation Oncology, Biology, Physics | GJ Haber JP Schiff MT Prusator JC Yang | 2023/10/1 |
510MO Trastuzumab deruxtecan (T-DXd) in Asian patients (Pts) with human epidermal growth factor receptor 2 (HER2; ERBB2)-mutant (HER2m) metastatic non-small cell lung cancer … | Annals of Oncology | Y Goto K Goto T Kubo K Ninomiya SW Kim | 2023/11/1 |
161O RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC) | Journal of Thoracic Oncology | CM Rudin A Dowlati Y Chen AF Navarro Mendivil JC-H Yang | 2023/4/1 |
Genome-wide analysis of mitochondrial DNA copy number reveals loci implicated in nucleotide metabolism, platelet activation, and megakaryocyte proliferation | Human genetics | RJ Longchamps SY Yang CA Castellani W Shi J Lane | 2022/1/1 |
PCR54 Patient Preferences for Treatment Alternatives for Drug-Resistant Epilepsy | Value in Health | JC Yang MJ Wallace K Grover R Johnson S Sinha | 2022/7/1 |
VP3-2022: Pembrolizumab (pembro) versus placebo for early-stage non-small cell lung cancer (NSCLC) following complete resection and adjuvant chemotherapy (chemo) when indicated … | Annals of Oncology | L Paz-Ares MER O'Brien M Mauer U Dafni K Oselin | 2022/4/1 |
